Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases

Human Immunology

Volumn 63, Issue 2, 2002, Pages 83-90

  Pangault, C ^a   Le Friec, G ^a   Caulet Maugendre, S ^b   Lena H ^c   Amiot, L ^a   Guilloux, V ^a   Onno, M ^a   Fauchet, R ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b Laboratoire d'Anatomo pathologie   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Dendritic cell; HLA G; Immunoregulation; Lung; Macrophage

Indexed keywords

HLA ANTIGEN CLASS 1; HLA G ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; DENDRITIC CELL; FEMALE; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; LUNG CANCER; LUNG DISEASE; MACROPHAGE; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR VOLUME;

DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LUNG; LUNG DISEASES; LUNG NEOPLASMS; MACROPHAGES; MALE;

EID: 0036171842     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(01)00373-1     Document Type: Article

References (53)

1. Natural history of HLA expression during tumour development
2. HLA and cancer: From research to clinical impact
3. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
4. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens
5. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes
6. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4
7. Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts
8. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells
9. A class I antigen, HLA-G, expressed in human trophoblasts
10. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
11. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells
12. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors?
13. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells
14. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily
15. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
16. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells
17. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes
18. HLA-G inhibits the allogeneic proliferative response
19. HLA-G protein expression is not induced during malignant transformation
20. Expression of HLA-G in human tumors is not a frequent event
21. Analysis of HLA-G expression in tumor cell lines
22. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma
23. HLA-G class I gene expression in normal and malignant hematopoietic cells
24. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
25. Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma
26. Revisions in the international system for staging lung cancer
27. Reaction patterns of monoclonal antibodies to HLA-G in human tissues and on cell lines: A comparative study
28. HLA-G,-E,-F preworkshop: Tools and protocols for analysis of non-classical class I genes transcription and protein expression
29. High frequency of altered HLA class I phenotypes in invasive breast carcinomas
30. High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas
31. High frequency of altered HLA class I phenotypes in laryngeal carcinomas
32. Multiple mechanisms underlie HLA dysregulation in cervical cancer
33. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: Clinical and immunogenetic consequences
34. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines
35. Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course
36. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer
37. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation
38. Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production
39. Looking for HLA-G expression in human tumours
40. Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted
41. Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G
42. Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines
43. Hla-g and nk receptor are expressed in psoriatic skin: A possible pathway for regulating infiltrating t cells?
44. Modulation of HLA-G antigens expression by human cytomegalovirus: Specific induction in activated macrophages harboring human cytomegalovirus infection
45. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
46. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer
47. Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors
48. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis
49. Autonomous expressions of cytokine genes by human lung cancer cells and their paracrine regulation
50. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua- associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor
51. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells
52. Hla-g2, -g3, and -g4 isoforms expressed as nonmature cell surface glycoproteins inhibit nk and antigen-specific ctl cytolysis
53. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules